About this Research Topic
Flow cytometry has wide applications in human and veterinary medicine and represents a powerful research tool as well as a very reliable method of diagnosis and assessment of therapy monitoring in immunology and hematology. It is able to correlate several characteristics of single cells, both qualitative and quantitative, and nowadays is no longer used for research purposes only, but has wide applications in clinical testing. Moreover, since less expensive instruments have become available together with a wide range of fluorescent monoclonal antibodies, new opportunities for routine diagnosis and disease management have emerged for clinical laboratories since detailed analysis of complex populations in a short period of time is now possible.
Currently, there are many research groups, as well as clinicians, whose main interest is the use of flow cytometry for various applications in hematology or immunology. There is also an imperative need for standardized protocols and common efforts for harmonization of standard methodologies for cell analysis between groups. Moreover, sharing the results obtained by different laboratories under a well organized article collection could mean a better understanding of the most recent advances made in this field and a step forward towards new collaboration opportunities. The goal of this Research Topic is to advance knowledge by offering the opportunity to specialists who work with flow cytometry to present their valuable work and results.
The current Research Topic is centered around the use of flow cytometry as a powerful tool for diagnosis and therapy monitoring and welcomes original contributions as well as review articles focusing on the use of this method for various applications in hematology or immunology, including (but not limited to):
- DNA content analysis
- cancer detection, classification, and clinical management
- leukemia and lymphoma phenotyping
- immunophenotyping
- immunologic monitoring of HIV-infected individuals
- minimal residual disease detection
- drug-susceptibility testing
- diagnosis of primary and secondary immunodeficiency disorders
- diagnosis of rare hematologic disorders as well as autoimmune/autoinflammatory disorders
- platelet activity
Currently, there are many research groups, as well as clinicians, whose main interest is the use of flow cytometry for various applications in hematology or immunology. There is also an imperative need for standardized protocols and common efforts for harmonization of standard methodologies for cell analysis between groups. Moreover, sharing the results obtained by different laboratories under a well organized article collection could mean a better understanding of the most recent advances made in this field and a step forward towards new collaboration opportunities. The goal of this Research Topic is to advance knowledge by offering the opportunity to specialists who work with flow cytometry to present their valuable work and results.
The current Research Topic is centered around the use of flow cytometry as a powerful tool for diagnosis and therapy monitoring and welcomes original contributions as well as review articles focusing on the use of this method for various applications in hematology or immunology, including (but not limited to):
- DNA content analysis
- cancer detection, classification, and clinical management
- leukemia and lymphoma phenotyping
- immunophenotyping
- immunologic monitoring of HIV-infected individuals
- minimal residual disease detection
- drug-susceptibility testing
- diagnosis of primary and secondary immunodeficiency disorders
- diagnosis of rare hematologic disorders as well as autoimmune/autoinflammatory disorders
- platelet activity
Keywords: flow cytometry, hematology, immunology, diagnosis, therapy monitoring
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
